- Home
- ASYS vs MIST Comparison
ASYS vs MIST Comparison
Compare ASYS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- MIST
- Stock Information
- Founded
- ASYS 1981
- MIST 2003
- Country
- ASYS United States
- MIST Canada
- Employees
- ASYS N/A
- MIST N/A
- Industry
- ASYS Industrial Machinery/Components
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- MIST Health Care
- Exchange
- ASYS Nasdaq
- MIST Nasdaq
- Market Cap
- ASYS 59.4M
- MIST 89.8M
- IPO Year
- ASYS N/A
- MIST N/A
- Fundamental
- Price
- ASYS $4.60
- MIST $1.45
- Analyst Decision
- ASYS
- MIST Strong Buy
- Analyst Count
- ASYS 0
- MIST 2
- Target Price
- ASYS N/A
- MIST $7.50
- AVG Volume (30 Days)
- ASYS 39.6K
- MIST 2.2M
- Earning Date
- ASYS 08-06-2025
- MIST 08-07-2025
- Dividend Yield
- ASYS N/A
- MIST N/A
- EPS Growth
- ASYS N/A
- MIST N/A
- EPS
- ASYS N/A
- MIST N/A
- Revenue
- ASYS $90,826,000.00
- MIST N/A
- Revenue This Year
- ASYS N/A
- MIST N/A
- Revenue Next Year
- ASYS $28.60
- MIST N/A
- P/E Ratio
- ASYS N/A
- MIST N/A
- Revenue Growth
- ASYS N/A
- MIST N/A
- 52 Week Low
- ASYS $3.20
- MIST $0.63
- 52 Week High
- ASYS $6.96
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- ASYS 56.56
- MIST 41.19
- Support Level
- ASYS $4.55
- MIST $1.36
- Resistance Level
- ASYS $4.94
- MIST $2.56
- Average True Range (ATR)
- ASYS 0.25
- MIST 0.18
- MACD
- ASYS 0.00
- MIST -0.07
- Stochastic Oscillator
- ASYS 66.34
- MIST 9.99
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).